Endocytosis in cancer and cancer therapy.

Mellman, I. & Yarden, Y. Endocytosis and cancer. Cold Spring Harb. Perspect. Biol. 5, a016949 (2013).

pmcid: 3839607 doi: 10.1101/cshperspect.a016949

Goh, L. K. & Sorkin, A. Endocytosis of receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 5, a017459 (2013).

pmcid: 3632065 doi: 10.1101/cshperspect.a017459

Dacks, J. B., Poon, P. P. & Field, M. C. Phylogeny of endocytic components yields insight into the process of nonendosymbiotic organelle evolution. Proc. Natl Acad. Sci. USA 105, 588–593 (2008).

pmcid: 2206580 doi: 10.1073/pnas.0707318105

Uribe-Querol, E. & Rosales, C. Phagocytosis: our current understanding of a universal biological process. Front. Immunol. 11, 1066 (2020).

pmcid: 7280488 doi: 10.3389/fimmu.2020.01066

Stow, J. L., Hung, Y. & Wall, A. A. Macropinocytosis: insights from immunology and cancer. Curr. Opin. Cell Biol. 65, 131–140 (2020). A comprehensive, topical and thought-provoking review on macropinocytosis.

doi: 10.1016/j.ceb.2020.06.005

Sandvig, K., Kavaliauskiene, S. & Skotland, T. Clathrin-independent endocytosis: an increasing degree of complexity. Histochem. Cell Biol. 150, 107–118 (2018).

pmcid: 6096564 doi: 10.1007/s00418-018-1678-5

Thottacherry, J. J., Sathe, M., Prabhakara, C. & Mayor, S. Spoiled for choice: diverse endocytic pathways function at the cell surface. Annu. Rev. Cell. Dev. Biol. 35, 55–84 (2019). A comprehensive and topical review of clathrin-dependent and clathrin-independent endocytic pathways.

pmcid: 6917507 doi: 10.1146/annurev-cellbio-100617-062710

Howes, M. T. et al. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J. Cell Biol. 190, 675–691 (2010).

pmcid: 2928008 doi: 10.1083/jcb.201002119

Elkin, S. R. et al. A systematic analysis reveals heterogeneous changes in the endocytic activities of cancer cells. Cancer Res. 75, 4640–4650 (2015).

pmcid: 4802864 doi: 10.1158/0008-5472.CAN-15-0939

Schmid, S. L. Reciprocal regulation of signaling and endocytosis: implications for the evolving cancer cell. J. Cell Biol. 216, 2623–2632 (2017). This review demonstrates the heterogeneity of endocytosis in cancer cells.

pmcid: 5584184 doi: 10.1083/jcb.201705017

Sorkin, A. & Von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609–622 (2009).

pmcid: 2895425 doi: 10.1038/nrm2748

Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

pubmed: 21376230 doi: 10.1016/j.cell.2011.02.013

Lanzetti, L. & Di Fiore, P. P. Endocytosis and cancer: an ‘insider’ network with dangerous liaisons. Traffic 9, 2011–2021 (2008).

doi: 10.1111/j.1600-0854.2008.00816.x

Sigismund, S., Lanzetti, L., Scita, G. & Di Fiore, P. P. Endocytosis in the context-dependent regulation of individual and collective cell properties. Nat. Rev. Mol. Cell Biol. 22, 625–643 (2021).

doi: 10.1038/s41580-021-00375-5

Rennick, J. J., Johnston, A. P. R. & Parton, R. G. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat. Nanotechnol. 16, 266–276 (2021). This review serves as a guide to studying endocytosis. Although focused on endocytosis of therapeutics, the principles outlined apply to all studies of endocytic pathways.

doi: 10.1038/s41565-021-00858-8

Pereira, P. M. R., Mandleywala, K., Ragupathi, A. & Lewis, J. S. Acute statin treatment improves antibody accumulation in EGFR- and PSMA-expressing tumors. Clin. Cancer Res. 26, 6215–6229 (2020).

pmcid: 8329749 doi: 10.1158/1078-0432.CCR-20-1960

Sigismund, S. et al. Clathrin-independent endocytosis of ubiquitinated cargos. Proc. Natl Acad. Sci. USA 102, 2760–2765 (2005).

pmcid: 549482 doi: 10.1073/pnas.0409817102

Watanabe, S. & Boucrot, E. Fast and ultrafast endocytosis. Curr. Opin. Cell Biol. 47, 64–71 (2017). This review characterizes FEME.

doi: 10.1016/j.ceb.2017.02.013

Shah, C. et al. Structural insights into membrane interaction and caveolar targeting of dynamin-like EHD2. Structure 22, 409–420 (2014).

pmcid: 3979964 doi: 10.1016/j.str.2013.12.015

Renard, H.-F. et al. Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis. Nature 517, 493–496 (2015).

doi: 10.1038/nature14064

Yue, H.-Y. & Xu, J. Cholesterol regulates multiple forms of vesicle endocytosis at a mammalian central synapse. J. Neurochem. 134, 247–260 (2015). This study demonstrates the ubiquitous involvement of cholesterol in cellular trafficking pathways.

pmcid: 4490978 doi: 10.1111/jnc.13129

Larsson, E., Morén, B., McMahon, K.-A., Parton, R. G. & Lundmark, R. Dynamin2 functions as an accessory protein to reduce the rate of caveola internalization. J. Cell Biol. 222, e202205122 (2023). This paper addresses the role of endocytic proteins in caveolae.

pmcid: 9929934 doi: 10.1083/jcb.202205122

MacDonald, P. E. & Rorsman, P. The ins and outs of secretion from pancreatic β-cells: control of single-vesicle exo- and endocytosis. Physiology 22, 113–121 (2007).

doi: 10.1152/physiol.00047.2006

Ma, C.-I. J., Burgess, J. & Brill, J. A. Maturing secretory granules: where secretory and endocytic pathways converge. Adv. Biol. Regul. 80, 100807 (2021).

doi: 10.1016/j.jbior.2021.100807

Sitaram, A. & Marks, M. S. Mechanisms of protein delivery to melanosomes in pigment cells. Physiology 27, 85–99 (2012).

doi: 10.1152/physiol.00043.2011

Burgoyne, R. D. & Morgan, A. Secretory granule exocytosis. Physiol. Rev. 83, 581–632 (2003).

doi: 10.1152/physrev.00031.2002

de Saint Basile, G., Ménasché, G. & Fischer, A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat. Rev. Immunol. 10, 568–579 (2010).

doi: 10.1038/nri2803

Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464–470 (2021). A topical review on endocytosis in antigen recognition and immune programming.

pmcid: 7969354 doi: 10.1038/s41586-020-03144-0

Birn, H., Nielsen, S. & Christensen, E. I. Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule. Am. J. Physiol. Ren. Physiol. 272, F70–F78 (1997).

doi: 10.1152/ajprenal.1997.272.1.F70

Dunn, K. W. et al. Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am. J. Physiol. Cell Physiol. 283, 905–916 (2002). A rare study examining endocytosis in vivo.

doi: 10.1152/ajpcell.00159.2002

Khandelwal, P., Ruiz, W. G. & Apodaca, G. Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway. EMBO J. 29, 1961–1975 (2010).

pmcid: 2892371 doi: 10.1038/emboj.2010.91

Nakhoul, N. & Batuman, V. Role of proximal tubules in the pathogenesis of kidney disease. Contrib. Nephrol. 169, 37–50 (2011).

doi: 10.1159/000313944

Rosendale, M. & Perrais, D. Imaging in focus: Imaging the dynamics of endocytosis. Int. J. Biochem. Cell Biol. 93, 41–45 (2017).

doi: 10.1016/j.biocel.2017.10.010

Amornphimoltham, P., Masedunskas, A. & Weigert, R. Intravital microscopy as a tool to study drug delivery in preclinical studies. Adv. Drug Del. Rev. 63, 119–128 (2011).

doi: 10.1016/j.addr.2010.09.009

Pinilla-Macua, I., Grassart, A., Duvvuri, U., Watkins, S. C. & Sorkin, A. EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo. eLife 6, e31993 (2017).

pmcid: 5741375 doi: 10.7554/eLife.31993

Schuh, C. D. et al. Combined structural and functional imaging of the kidney reveals major axial differences in proximal tubule endocytosis. J. Am. Soc. Nephrol. 29, 2696–2712 (2018).

pmcid: 6218873 doi: 10.1681/ASN.2018050522

Chen, P.-H. et al. Crosstalk between CLCb/Dyn1-mediated adaptive clathrin-mediated endocytosis and epidermal growth factor receptor signaling increases metastasis. Dev. Cell 40, 278–288 (2017).

pmcid: 5740869 doi: 10.1016/j.devcel.2017.01.007

Schuuring, E., Verhoeven, E., Mooi, W. J. & Michalides, R. J. A. M. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7, 355–361 (1992).

Sargin, B. et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 110, 1004–1012 (2007).

doi: 10.1182/blood-2007-01-066076

Koo, B.-K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665–669 (2012).

doi: 10.1038/nature11308

Robinson, B. S. & Moberg, K. H. Drosophila endocytic neoplastic tumor suppressor genes regulate Sav/Wts/Hpo signaling and the c-Jun N-terminal kinase pathway. Cell Cycle 10, 4110–4118 (2011).

pmcid: 3272291 doi: 10.4161/cc.10.23.18243

Gupta, R., Toufaily, C. & Annabi, B. Caveolin and cavin family members: dual roles in cancer. Biochimie 107, 188–202 (2014).

doi: 10.1016/j.biochi.2014.09.010

Li, D., Guo, Y., Tian, S., Zhu, C. & Sun, C. CAV2 regulates Mir-4723/Wnt7A signalling axis through endocytosis and epithelial-mesenchymal transition to promote proliferation, invasion, and metastasis of pancreatic cancer cells. J. Cancer 13, 2200–2212 (2022).

pmcid: 9066196 doi: 10.7150/jca.69617

Liu, F., Shangli, Z. & Hu, Z. CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway. OncoTargets Ther. 11, 6209–6216 (2018).

doi: 10.2147/OTT.S172803

Li, G. & Marlin, M. C. Rab family of GTPases. Methods Mol. Biol. 1298, 1–15 (2015).

pmcid: 5903570 doi: 10.1007/978-1-4939-2569-8_1

Johnson, I. R. D. et al. Endosomal gene expression: a new indicator for prostate cancer patient prognosis? Oncotarget 6, 37919–37929 (2015).

pmcid: 4741974 doi: 10.18632/oncotarget.6114

Thomas, J. D. et al. Rab1A Is an mTORC1 activator and a colorectal oncogene. Cancer Cell 26, 754–769 (2014).

pmcid: 4288827 doi: 10.1016/j.ccell.2014.09.008

Wheeler, D. B., Zoncu, R., Root, D. E., Sabatini, D. M. & Sawyers, C. L. Identification of an oncogenic RAB protein. Science 350, 211–217 (2015).

pmcid: 4600465 doi: 10.1126/science.aaa4903

Jin, H. et al. Rab GTPases: central coordinators of membrane trafficking in cancer. Front. Cell Dev. Biol. 9, 648384 (2021).

pmcid: 8204108 doi: 10.3389/fcell.2021.648384

Qin, X. et al. Targeting Rabs as a novel therapeutic strategy for cancer therapy. Drug. Discov. Today 22, 1139–1147 (2017).

doi: 10.1016/j.drudis.2017.03.012

Raffaniello, R. D. Rab3 proteins and cancer: exit strategies. J. Cell. Biochem. 122, 1295–1301 (2021).

doi: 10.1002/jcb.29948

Finicle, B. T., Jayashankar, V. & Edinger, A. L. Nutrient scavenging in cancer. Nat. Rev. Cancer 18, 619–633 (2018).

doi: 10.1038/s41568-018-0048-x

Forster, J. C., Harriss-Phillips, W. M., Douglass, M. J. & Bezak, E. A review of the development of tumor vasculature and its effects on the tumor microenvironment. Hypoxia 5, 21–32 (2017).

pmcid: 5395278 doi: 10.2147/HP.S133231

Provenzano, P. P. et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21, 418–429 (2012).

pubmed: 22439937 pmcid: 3371414 doi: 10.1016/j.ccr.2012.01.007

Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237–248 (2005).

doi: 10.1016/j.cell.2004.11.046

Su, H. et al. Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis. Cancer Cell 39, 678–693 (2021).

pmcid: 8119368 doi: 10.1016/j.ccell.2021.02.016

Zhang, M. S. et al. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nat. Commun. 13, 954 (2022).

pmcid: 8854584 doi: 10.1038/s41467-022-28618-9

Byun, J.-K. et al. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 41, 98 (2022).

pmcid: 8919615 doi: 10.1186/s13046-022-02296-3

Delikatny, E. J., Chawla, S., Leung, D.-J. & Poptani, H. MR-visible lipids and the tumor microenvironment. NMR Biomed. 24, 592–611 (2011).

pmcid: 3640643

Olzmann, J. A. & Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 20, 137–155 (2019).

pmcid: 6746329 doi: 10.1038/s41580-018-0085-z

Gharpure, K. M. et al. FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat. Commun. 9, 2923 (2018).

pmcid: 6062524 doi: 10.1038/s41467-018-04987-y

Zhang, M. et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 8, 1006–1025 (2018).

pmcid: 6192670 doi: 10.1158/2159-8290.CD-17-1371

Watt, M. J. et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci. Transl. Med. 11, eaau5758 (2019).

doi: 10.1126/scitranslmed.aau5758

Bi, J. et al. Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets. Nat. Rev. Cancer 20, 57–70 (2020).

doi: 10.1038/s41568-019-0226-5

Mulcahy, L. A., Pink, R. C. & Carter, D. R. F. Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles 3, 24641 (2014).

doi: 10.3402/jev.v3.24641

Cerezo-Magaña, M., Christianson, H. C., Van Kuppevelt, T. H., Forsberg-Nilsson, K. & Belting, M. Hypoxic induction of exosome uptake through proteoglycan-dependent endocytosis fuels the lipid droplet phenotype in glioma. Mol. Cancer Res. 19, 528–540 (2021).

doi: 10.1158/1541-7786.MCR-20-0560

Li, P. et al. Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis. Nat. Immunol. 21, 1444–1455 (2020). This study demonstrates metabolic crosstalk between neutrophils and metastatic tumour cells in the form of endocytosis of lipids, which in turn supports cancer cell growth.

pmcid: 7584447 doi: 10.1038/s41590-020-0783-5

Zhang, Y. et al. Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2/ARHGEF2 signaling and functions to support tumor and stromal cell fitness. Cancer Discov. 11, 1808–1825 (2021).

pmcid: 8292164 doi: 10.1158/2159-8290.CD-20-0119

Bar-Sagi, D. & Feramisco, J. R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233, 1061–1068 (1986).

doi: 10.1126/science.3090687

Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D. & Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401–410 (1992).

doi: 10.1016/0092-8674(92)90164-8

Ryan, M. B. & Corcoran, R. B. Therapeutic strategies to target RAS-mutant cancers. Nat. Rev. Clin. Oncol. 15, 709–720 (2018).

doi: 10.1038/s41571-018-0105-0

Raphael, B. J. et al. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185–203 (2017).

doi: 10.1016/j.ccell.2017.07.007

Commisso, C. et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633–637 (2013).

pmcid: 3810415 doi: 10.1038/nature12138

Prior, I. A., Hood, F. E. & Hartley, J. L. The frequency of Ras mutations in cancer. Cancer Res. 80, 2969–2974 (2020).

pubmed: 32209560 pmcid: 7367715 doi: 10.1158/0008-5472.CAN-19-3682

Davidson, S. M. et al. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat. Med. 23, 235–241 (2017).

doi: 10.1038/nm.4256

Hobbs, G. A. & Der, C. J. Binge drinking: macropinocytosis promotes tumorigenic growth of RAS-mutant cancers. Trends Biochem. Sci. 45, 459–461 (2020).

doi: 10.1016/j.tibs.2020.02.009

Hobbs, G. A. et al. Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer. Cancer Discov. 10, 104–123 (2020).

doi: 10.1158/2159-8290.CD-19-1006

King, B., Araki, J., Palm, W. & Thompson, C. B. Yap/Taz promote the scavenging of extracellular nutrients through macropinocytosis. Genes Dev. 34, 1345–1358 (2020).

pmcid: 7528706 doi: 10.1101/gad.340661.120

O’Bryan, J. P. et al. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol. 11, 5016–5031 (1991).

pmcid: 361494

Goyette, M.-A. & Côté, J.-F. AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis. Cancers 14, 466 (2022).

pmcid: 8833413 doi: 10.3390/cancers14030466

Zdżalik-Bielecka, D. et al. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion. Proc. Natl Acad. Sci. USA 118, e2024596118 (2021). This paper provides mechanistic detail of the signalling that drives macropinocytosis and cancer cell invasion.

pmcid: 8285903 doi: 10.1073/pnas.2024596118

Liu, H. et al. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs. J. Control. Release 296, 40–53 (2019).

doi: 10.1016/j.jconrel.2019.01.014

Kratz, F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132, 171–183 (2008).

doi: 10.1016/j.jconrel.2008.05.010

Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res. 46, 6387–6392 (1986).

Nazha, B., Moussaly, E., Zaarour, M., Weerasinghe, C. & Azab, B. Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate? World J. Gastrointest. Surg. 7, 370–377 (2015).

pmcid: 4691717 doi: 10.4240/wjgs.v7.i12.370

Fujii, T. et al. Implications of low serum albumin as a prognostic factor of long-term outcomes in patients with breast cancer. Vivo 34, 2033–2036 (2020).

doi: 10.21873/invivo.12003

Kang, B. et al. Effect of hypoalbuminemia on short-term outcomes after colorectal cancer surgery: a propensity score matching analysis. Front. Nutr. 9, 925086 (2022).

pmcid: 9464913 doi: 10.3389/fnut.2022.925086

Sutton, M. N. et al. RAS-driven macropinocytosis of albumin or dextran reveals mutation-specific target engagement of RAS p.G12C inhibitor ARS-1620 by NIR-fluorescence imaging. Mol. Imag. Biol. 24, 498–509 (2022).

doi: 10.1007/s11307-021-01689-8

Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544–553 (2015).

pubmed: 25644265 pmcid: 4316379 doi: 10.1158/0008-5472.CAN-14-2211

Bern, M., Sand, K. M. K., Nilsen, J., Sandlie, I. & Andersen, J. T. The role of albumin receptors in regulation of albumin homeostasis: implications for drug delivery. J. Control. Release 211, 144–162 (2015).

pubmed: 26055641 doi: 10.1016/j.jconrel.2015.06.006

Swiercz, R. et al. Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption. Oncotarget 8, 3528–3541 (2017).

pubmed: 27974681 doi: 10.18632/oncotarget.13869

Baker, K. et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b

pubmed: 21628593 pmcid: 3116387 doi: 10.1073/pnas.1019037108

Baker, K. et al. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 39, 1095–1107 (2013).

pubmed: 24290911 pmcid: 3902970 doi: 10.1016/j.immuni.2013.11.003

Dalloneau, E. et al. Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis. Oncotarget 7, 54415–54429 (2016).

pubmed: 27384673 pmcid: 5342352 doi: 10.18632/oncotarget.10074

Torphy, R. J. et al. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. Nat. Commun. 13, 97 (2022).

pubmed: 35013216 pmcid: 8748779 doi: 10.1038/s41467-021-27658-x

Xing, Q. et al. Scavenger receptor MARCO contributes to macrophage phagocytosis and clearance of tumor cells. Exp. Cell Res. 408, 112862–112871 (2021).

pubmed: 34626585 doi: 10.1016/j.yexcr.2021.112862

Plygawko, A. T., Kan, S. & Campbell, K. Epithelial–mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis. Philos. Trans. R. Soc. B Biol. Sci. 375, 20200087 (2020).

doi: 10.1098/rstb.2020.0087

Bhatia, S., Wang, P., Toh, A. & Thompson, E. W. New insights into the role of phenotypic plasticity and EMT in driving cancer progression. Front. Mol. Biosci. 7, 71 (2020).

pubmed: 32391381 pmcid: 7190792 doi: 10.3389/fmolb.2020.00071

Mosesson, Y., Mills, G. B. & Yarden, Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 8, 835–850 (2008).

pubmed: 18948996 doi: 10.1038/nrc2521

Goossens, S., Vandamme, N., Van Vlierberghe, P. & Berx, G. EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim. Biophys. Acta Rev. Cancer 1868, 584–591 (2017).

doi: 10.1016/j.bbcan.2017.06.006

Castosa, R. et al. Hakai overexpression effectively induces tumour progression and metastasis in vivo. Sci. Rep. 8, 3466 (2018).

pmcid: 5823865 doi: 10.1038/s41598-018-21808-w

Fujita, Y. et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4, 222–231 (2002).

doi: 10.1038/ncb758

Katsuno-Kambe, H. & Yap, A. S. Endocytosis, cadherins and tissue dynamics. Traffic 21, 268–273 (2020).

doi: 10.1111/tra.12721

Schiano Lomoriello, I. et al. A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior. Nat. Commun. 11, 3020 (2020).

pubmed: 32541686 pmcid: 7296024 doi: 10.1038/s41467-020-16836-y

Choi, H. J. et al. Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression. BMB Rep. 50, 429–434 (2017).

pmcid: 5595173 doi: 10.5483/BMBRep.2017.50.8.097

Wang, S. E. et al. Transforming growth factor β induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res. 69, 475–482 (2009).

pmcid: 2629389 doi: 10.1158/0008-5472.CAN-08-2649

Manshouri, R. et al. ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer. Nat. Commun. 10, 5125 (2019).

pmcid: 6851102 doi: 10.1038/s41467-019-12832-z

Deng, Y. et al. Prognostic value of flotillins (flotillin-1 and flotillin-2) in human cancers: a meta-analysis. Clin. Chim. Acta 481, 90–98 (2018).

doi: 10.1016/j.cca.2018.02.036

Greenlee, J. D., Subramanian, T., Liu, K. & King, M. R. Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes. Cancer Res. 81, 5–17 (2021).

doi: 10.1158/0008-5472.CAN-20-2199

Doherty, S. D., Prieto, V. G., George, S., Hazarika, P. & Duvic, M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 16, 461–463 (2006).

doi: 10.1097/01.cmr.0000222592.75858.20

Glebov, O. O., Bright, N. A. & Nichols, B. J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 8, 46–54 (2006).

doi: 10.1038/ncb1342

Gauthier-Rouvière, C., Bodin, S., Comunale, F. & Planchon, D. Flotillin membrane domains in cancer. Cancer Metastasis Rev. 39, 361–374 (2020).

pmcid: 7311376 doi: 10.1007/s10555-020-09873-y

Genest, M. et al. Upregulated flotillins and sphingosine kinase 2 derail AXL vesicular traffic to promote epithelial-mesenchymal transition. J. Cell Sci. 135, jcs259178 (2022).

doi: 10.1242/jcs.259178

Antony, J. & Huang, R. Y.-J. AXL-driven EMT state as a targetable conduit in cancer. Cancer Res. 77, 3725–3732 (2017).

doi: 10.1158/0008-5472.CAN-17-0392

Rodriguez-Boulan, E. & Macara, I. G. Organization and execution of the epithelial polarity programme. Nat. Rev. Mol. Cell Biol. 15, 225–242 (2014).

pubmed: 24651541 pmcid: 4211427 doi: 10.1038/nrm3775

Thottacherry, J. J., Chen, J. & Johnston, D. S. Apical–basal polarity in the gut. Semin. Cell Dev. Biol. https://doi.org/10.1016/j.semcdb.2022.12.007 (2023).

doi: 10.1016/j.semcdb.2022.12.007 pubmed: 36670034

Shivas, J. M., Morrison, H. A., Bilder, D. & Skop, A. R. Polarity and endocytosis: reciprocal regulation. Trends Cell Biol. 20, 445–452 (2010).

pmcid: 2917511 doi: 10.1016/j.tcb.2010.04.003

Ballestrem, C., Hinz, B., Imhof, B. A. & Wehrle-Halle, B. Marching at the front and dragging behind differential αVβ3-integrin turnover regulates focal adhesion behavior. J. Cell Biol. 155, 1319–1332 (2001).

pmcid: 2199321 doi: 10.1083/jcb.200107107

Partridge, M. A. & Marcantonio, E. E. Initiation of attachment and generation of mature focal adhesions by integrin-containing filopodia in cell spreading. Mol. Biol. Cell 17, 4237–4248 (2006).

pmcid: 1635363 doi: 10.1091/mbc.e06-06-0496

Nader, G. P. F., Ezratty, E. J. & Gundersen, G. G. FAK, talin and PIPKIγ regulate endocytosed integrin activation to polarize focal adhesion assembly. Nat. Cell Biol. 18, 491–503 (2016).

pubmed: 27043085 doi: 10.1038/ncb3333

Banerjee, P. et al. The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells. Nat. Commun. 12, 6354 (2021).

pubmed: 34732702 pmcid: 8566461 doi: 10.1038/s41467-021-26677-y

Zhong, Y. et al. MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly. Cell Death Differ. 28, 3251–3269 (2021).

pubmed: 34131310 pmcid: 8629984 doi: 10.1038/s41418-021-00813-z

Cong, M. et al. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination. Nat. Cancer 1, 222–234 (2020).

pubmed: 35122005 doi: 10.1038/s43018-019-0021-y

Wu, Z. et al. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells. Cell Death Dis. 11, 881 (2020).

pmcid: 7575565 doi: 10.1038/s41419-020-03096-3

Zhu, J. et al. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression. Oncogene 39, 6776–6788 (2020).

pmcid: 7605433 doi: 10.1038/s41388-020-01464-z

Tsunoda, T. et al. ENTREP/FAM189A2 encodes a new ITCH ubiquitin ligase activator that is downregulated in breast cancer. EMBO Rep. 23, e51182 (2022).

doi: 10.15252/embr.202051182

Sposini, S. et al. Imaging endocytic vesicle formation at high spatial and temporal resolutions with the pulsed-pH protocol. Nat. Protoc. 15, 3088–3104 (2020).

doi: 10.1038/s41596-020-0371-z

Ranftler, C. et al. in Cell Imaging Techniques: Methods and Protocols (eds Taatjes, D. J. & Roth, J.) 437–447 (Humana Press, 2013).

Baek, J. et al. Imaging galectin-3 dependent endocytosis with lattice light-sheet microscopy. SPIE Proc. Int. Conf. Biophotonics V 10340, 103400J, https://doi.org/10.1117/12.2275706 (2017).

doi: 10.1117/12.2275706

Charpentier, J. C. & King, P. D. Mechanisms and functions of endocytosis in T cells. Cell Commun. Signal. 19, 92 (2021).

pmcid: 8427877 doi: 10.1186/s12964-021-00766-3

Burgdorf, S. & Kurts, C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr. Opin. Immunol. 20, 89–95 (2008).

pubmed: 18249105 doi: 10.1016/j.coi.2007.12.002

Compeer, E. B. et al. A mobile endocytic network connects clathrin-independent receptor endocytosis to recycling and promotes T cell activation. Nat. Commun. 9, 1597 (2018). This study describes the interplay between endocytosis and T cell responses.

pubmed: 29686427 pmcid: 5913236 doi: 10.1038/s41467-018-04088-w

Evnouchidou, I. et al. IRAP-dependent endosomal T cell receptor signalling is essential for T cell responses. Nat. Commun. 11, 2779 (2020).

pubmed: 32487999 pmcid: 7265453 doi: 10.1038/s41467-020-16471-7

Masilamani, M., Peruzzi, G., Borrego, F. & Coligan, J. E. Endocytosis and intracellular trafficking of human natural killer cell receptors. Traffic 10, 1735–1744 (2009).

pubmed: 19719476 pmcid: 2783697 doi: 10.1111/j.1600-0854.2009.00973.x

Béguin, E. P. et al. Endocytosis by macrophages: interplay of macrophage scavenger receptor-1 and LDL receptor-related protein-1. Haematologica 105, e133–e137 (2020).

pubmed: 31248969 pmcid: 7049352 doi: 10.3324/haematol.2018.210682

McShane, A. N. & Malinova, D. The ins and outs of antigen uptake in B cells. Front. Immunol. 13, 892169 (2022).

pubmed: 35572544 pmcid: 9097226 doi: 10.3389/fimmu.2022.892169

Lanzetti, L. & Di Fiore, P. P. Behind the scenes: endo/exocytosis in the acquisition of metastatic traits. Cancer Res. 77, 1813–1817 (2017). A comprehensive and topical review of endocytosis involvement in metastasis.

pubmed: 28373181 doi: 10.1158/0008-5472.CAN-16-3403

Khan, I. & Steeg, P. S. Endocytosis: a pivotal pathway for regulating metastasis. Br. J. Cancer 124, 66–75 (2021).

pubmed: 33262521 doi: 10.1038/s41416-020-01179-8

Safaei, S. et al. Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma. Cancer Biomark. 35, 27–45 (2022).

pubmed: 35662107 doi: 10.3233/CBM-210514

Wang, X. et al. lncRNA HITT inhibits metastasis by attenuating Rab5-mediated endocytosis in lung adenocarcinoma. Mol. Ther. 30, 1071–1088 (2022).

pubmed: 35017116 pmcid: 8899701 doi: 10.1016/j.ymthe.2022.01.014

Wang, D., Liu, S. & Wang, G. Establishment of an endocytosis-related prognostic signature for patients with low-grade glioma. Front. Genet. 12, 709666 (2021).

pubmed: 34552618 pmcid: 8450508 doi: 10.3389/fgene.2021.709666

Abu-Thuraia, A. et al. AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network. Nat. Commun. 11, 3586 (2020).

pubmed: 32681075 pmcid: 7368075 doi: 10.1038/s41467-020-17415-x

He, Z. et al. Dynamic regulation of KIF15 phosphorylation and acetylation promotes focal adhesions disassembly in pancreatic cancer. Cell Death Dis. 13, 896 (2022).

pubmed: 36280663 pmcid: 9592618 doi: 10.1038/s41419-022-05338-y

Ramsay, A. G. et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin αvβ6. Cancer Res. 67, 5275–5284 (2007).

pubmed: 17545607 doi: 10.1158/0008-5472.CAN-07-0318

de Beco, S., Gueudry, C., Amblard, F. & Coscoy, S. Endocytosis is required for E-cadherin redistribution at mature adherens junctions. Proc. Natl Acad. Sci. USA 106, 7010–7015 (2009).

pubmed: 19372377 pmcid: 2678428 doi: 10.1073/pnas.0811253106

Chen, H.-R. et al. DDR1 promotes E-cadherin stability via inhibition of integrin-β1-Src activation-mediated E-cadherin endocytosis. Sci. Rep. 6, 36336 (2016).

pubmed: 27824116 pmcid: 5099905 doi: 10.1038/srep36336

Diggins, N. L., Kang, H., Weaver, A. & Webb, D. J. α5β1 integrin trafficking and Rac activation are regulated by APPL1 in a Rab5-dependent manner to inhibit cell migration. J. Cell Sci. 131, jcs207019 (2018).

pubmed: 29361527 pmcid: 5897716 doi: 10.1242/jcs.207019

Cheung, K. J. et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc. Natl Acad. Sci. USA 113, E854–E863 (2016).

pubmed: 26831077 pmcid: 4763783 doi: 10.1073/pnas.1508541113

Ring, A., Spataro, M., Wicki, A. & Aceto, N. Clinical and biological aspects of disseminated tumor cells and dormancy in breast cancer. Front. Cell Dev. Biol. 10, 929893 (2022).

pubmed: 35837334 pmcid: 9274007 doi: 10.3389/fcell.2022.929893

Elkhatib, N., Porshneva, K. & Montagnac, G. Migration cues interpretation by clathrin-coated structures. Curr. Opin. Cell Biol. 72, 100–105 (2021).

pubmed: 34391036 doi: 10.1016/j.ceb.2021.07.005

Wang, L.-T., Rajah, A., Brown, C. M. & McCaffrey, L. CD13 orients the apical-basal polarity axis necessary for lumen formation. Nat. Commun. 12, 4697 (2021).

pubmed: 34349123 pmcid: 8338993 doi: 10.1038/s41467-021-24993-x

Bretscher, M. S. Endocytosis and recycling of the fibronectin receptor in CHO cells. EMBO J. 8, 1341–1348 (1989).

pubmed: 2527741 pmcid: 400960 doi: 10.1002/j.1460-2075.1989.tb03514.x

Rappoport, J. Z. & Simon, S. M. Real-time analysis of clathrin-mediated endocytosis during cell migration. J. Cell Sci. 116, 847–855 (2003).

pubmed: 12571282 doi: 10.1242/jcs.00289

Powelka, A. M. et al. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 5, 20–36 (2004).

pubmed: 14675422 doi: 10.1111/j.1600-0854.2004.00150.x

Moreno-Layseca, P. et al. Cargo-specific recruitment in clathrin- and dynamin-independent endocytosis. Nat. Cell Biol. 23, 1073–1084 (2021). An elegant study of cargo selection in endocytic pathways.

pubmed: 34616024 doi: 10.1038/s41556-021-00767-x

Xu, H. et al. Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin αvβ3/FAK/PI3K pathway-mediated Rac1 activation. J. Biosci. 42, 491–499 (2017).

pubmed: 29358562 doi: 10.1007/s12038-017-9699-0

Tehran, D. A., López-Hernández, T. & Maritzen, T. Endocytic adaptor proteins in health and disease: lessons from model organisms and human mutations. Cells 8, 1345 (2019).

doi: 10.3390/cells8111345

Raman, D., Sai, J., Hawkins, O. & Richmond, A. Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration. Traffic 15, 451–469 (2014).

pubmed: 24450359 pmcid: 3966550 doi: 10.1111/tra.12154

Xu, B. et al. The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Med. 3, 14–24 (2014).

pubmed: 24402972 doi: 10.1002/cam4.168

Chen, P.-W., Gasilina, A., Yadav, M. P. & Randazzo, P. A. Control of cell signaling by Arf GTPases and their regulators: focus on links to cancer and other GTPase families. Biochim. Biophys. Acta Mol. Cell Res. 1869, 119171 (2022).

pubmed: 34774605 doi: 10.1016/j.bbamcr.2021.119171

Qi, S. et al. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes. J. Exp. Clin. Cancer Res. 38, 471 (2019).

pubmed: 31752956 pmcid: 6868876 doi: 10.1186/s13046-019-1464-9

Parton, R. G., Tillu, V., McMahon, K.-A. & Collins, B. M. Key phases in the formation of caveolae. Curr. Opin. Cell Biol. 71, 7–14 (2021).

pubmed: 33677149 doi: 10.1016/j.ceb.2021.01.009

Singh, V. & Lamaze, C. Membrane tension buffering by caveolae: a role in cancer? Cancer Metastasis Rev. 39, 505–517 (2020).

pubmed: 32474691 doi: 10.1007/s10555-020-09899-2

Joshi, B. et al. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res. 68, 8210–8220 (2008).

pubmed: 18922892 doi: 10.1158/0008-5472.CAN-08-0343

Combedazou, A. et al. Small GTPases orchestrate cell-cell communication during collective cell movement. Small GTPases 11, 103–112 (2020).

pubmed: 28980871 doi: 10.1080/21541248.2017.1366965

Olayioye, M. A., Noll, B. & Hausser, A. Spatiotemporal control of intracellular membrane trafficking by Rho GTPases. Cells 8, 1478 (2019).

pubmed: 31766364 pmcid: 6952795 doi: 10.3390/cells8121478

Wang, T. et al. RHO GTPase family in hepatocellular carcinoma. Exp. Hematol. Oncol. 11, 91 (2022).

pubmed: 36348464 pmcid: 9644471 doi: 10.1186/s40164-022-00344-4

Zhang, J., Jiang, Z. & Shi, A. Rab GTPases: the principal players in crafting the regulatory landscape of endosomal trafficking. Comput. Struct. Biotechnol. J. 20, 4464–4472 (2022).

pubmed: 36051867 pmcid: 9418685 doi: 10.1016/j.csbj.2022.08.016

Sun, L. et al. Rab34 regulates adhesion, migration, and invasion of breast cancer cells. Oncogene 37, 3698–3714 (2018).

pubmed: 29622794 doi: 10.1038/s41388-018-0202-7

Yu, M. H., Luo, Y., Qin, S. L. & Zhong, M. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. Int. J. Exp. Pathol. 8, 6974–6980 (2015).

Wen, F. et al. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma. Front. Immunol. 14, 1086342 (2023).

pubmed: 36936971 pmcid: 10021109 doi: 10.3389/fimmu.2023.1086342

Liu, Q. et al. High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. Sci. Rep. 12, 17492 (2022).

pubmed: 36261459 pmcid: 9582019 doi: 10.1038/s41598-022-22355-1

Jiang, Y. et al. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion. Tumor Biol. 37, 8131–8138 (2016).

doi: 10.1007/s13277-015-4590-9

Luo, X. et al. Rab22a promotes epithelial-mesenchymal transition in papillary thyroid carcinoma by activating PI3K/AKT/mTOR signaling pathway. Biomed. Res. Int. 2022, 1874550 (2022).

pubmed: 35757470 pmcid: 9217539 doi: 10.1155/2022/1874550

Mavrakis, M. & Juanes, M. A. The compass to follow: focal adhesion turnover. Curr. Opin. Cell Biol. 80, 102152 (2023).

pubmed: 36796142 doi: 10.1016/j.ceb.2023.102152

Lundmark, R. et al. The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr. Biol. 8, 1802–1808 (2008).

doi: 10.1016/j.cub.2008.10.044

Sathe, M. et al. Small GTPases and BAR domain proteins regulate branched actin polymerisation for clathrin and dynamin-independent endocytosis. Nat. Commun. 9, 1835 (2018).

pubmed: 29743604 pmcid: 5943408 doi: 10.1038/s41467-018-03955-w

Bergers, G. & Fendt, S.-M. The metabolism of cancer cells during metastasis. Nat. Rev. Cancer 21, 162–180 (2021).

pubmed: 33462499 pmcid: 8733955 doi: 10.1038/s41568-020-00320-2

Zhang, S. et al. Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. Proc. Natl Acad. Sci. USA 119, e2117013119 (2022).

pubmed: 35259022 pmcid: 8931372 doi: 10.1073/pnas.2117013119

Boissan, M. et al. Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling. Science 344, 1510–1515 (2014).

pubmed: 24970086 pmcid: 4601533 doi: 10.1126/science.1253768

Dammai, V. Drosophila awd, the homolog of human nm23, regulates FGF receptor levels and functions synergistically with shi/dynamin during tracheal development. Genes Dev. 17, 2812–2824 (2003).

pubmed: 14630942 pmcid: 280629 doi: 10.1101/gad.1096903

Ignesti, M. et al. Notch signaling during development requires the function of awd, the Drosophila homolog of human metastasis suppressor gene Nm23. BMC Biol. 12, 12 (2014).

pmcid: 3937027 doi: 10.1186/1741-7007-12-12

Khan, I., Gril, B. & Steeg, P. S. Metastasis suppressors NME1 and NME2 promote dynamin 2 oligomerization and regulate tumor cell endocytosis, motility, and metastasis. Cancer Res. 79, 4689–4702 (2019).

pubmed: 31311812 pmcid: 8288561 doi: 10.1158/0008-5472.CAN-19-0492

Nallamothu, G., Woolworth, J. A., Dammai, V. & Hsu, T. Awd, the homolog of metastasis suppressor gene Nm23, regulates Drosophila epithelial cell invasion. Mol. Cell. Biol. 28, 1964–1973 (2008).

pmcid: 2268403 doi: 10.1128/MCB.01743-07

Woolworth, J. A., Nallamothu, G. & Hsu, T. The Drosophila metastasis suppressor gene nm23 homolog, awd, regulates epithelial integrity during oogenesis. Mol. Cell. Biol. 29, 4679–4690 (2009).

pmcid: 2725718 doi: 10.1128/MCB.00297-09

Schlattner, U. The complex functions of the NME family — a matter of location and molecular activity. Int. J. Mol. Sci. 22, 13083 (2021).

pubmed: 34884887 pmcid: 8658066 doi: 10.3390/ijms222313083

Kaźmierczak, Z. et al. Endocytosis in cellular uptake of drug delivery vectors: molecular aspects in drug development. Bioorg. Med. Chem. 28, 115556 (2020).

pubmed: 32828419 doi: 10.1016/j.bmc.2020.115556

Ge, Y., Huang, M. & Yao, Y.-M. The effect and regulatory mechanism of high mobility group box-1 protein on immune cells in inflammatory diseases. Cells 10, 1044 (2021).

pubmed: 33925132 pmcid: 8145631 doi: 10.3390/cells10051044

Gao, Q. et al. High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation. Cancer Immunol. Res. 10, 844–855 (2022).

pubmed: 35580259 doi: 10.1158/2326-6066.CIR-21-0652

Scott, A. M., Wolchok, J. D. & Old, L. J. Antibody therapy of cancer. Nat. Rev. Cancer 12, 278–287 (2012). A perspective on applying knowledge of endocytosis to drug delivery design.

pubmed: 22437872 doi: 10.1038/nrc3236

Roghanian, A. et al. Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo. Cancer Cell 27, 473–488 (2015).

pubmed: 25873171 doi: 10.1016/j.ccell.2015.03.005

Chew, H. Y. et al. Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies. Cell 180, 895–914 (2020). This study demonstrates that endocytosis can be temporarily and reversibly inhibited in humans in the clinical setting.

pubmed: 32142680 doi: 10.1016/j.cell.2020.02.019

Pereira, P. M. R. et al. Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy. Nat. Commun. 9, 5137 (2018). This study demonstrates effects of endocytosis on trastuzumab binding and efficacy.

pubmed: 30510281 pmcid: 6277446 doi: 10.1038/s41467-018-07608-w

Scaltriti, M. et al. Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene 28, 803–814 (2009).

pubmed: 19060928 doi: 10.1038/onc.2008.432

Tibbetts, R. et al. Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance. Cancer Immunol. Immunother. 71, 153–164 (2022).

pubmed: 34043024 doi: 10.1007/s00262-021-02963-y

Ritchie, M., Tchistiakova, L. & Scott, N. Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates. mAbs 5, 13–21 (2013).

pubmed: 23221464 pmcid: 3564878 doi: 10.4161/mabs.22854

Tsurutani, J. et al. Targeting HER2 with trastuzumab deruxtecan: a dose-expansion, phase I study in multiple advanced solid tumors. Cancer Discov. 10, 688–701 (2020).

pmcid: 8292921 doi: 10.1158/2159-8290.CD-19-1014

Yan, H., Yu, K., Zhang, K., Liu, L. & Li, Y. Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC): a meta-analysis of randomized controlled trial. Oncotarget 8, 102458–102467 (2017).

pmcid: 5731971 doi: 10.18632/oncotarget.22270

Li, B. T. et al. HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers. Cancer Discov. 10, 674–687 (2020).

pmcid: 7196485 doi: 10.1158/2159-8290.CD-20-0215

Robichaux, J. P. et al. Pan-cancer landscape and analysis of ERBB2 mutations identifies poziotinib as a clinically active inhibitor and enhancer of T-DM1 activity. Cancer Cell 36, 444–457 (2019).

pmcid: 6944069 doi: 10.1016/j.ccell.2019.09.001

Joseph, S. R. et al. Antibody/ligand-target receptor internalization assay protocol using fresh human or murine tumor ex vivo samples. Star. Protoc. 1, 100087 (2020).

pmcid: 7580087 doi: 10.1016/j.xpro.2020.100087

Joseph, S. R. et al. An ex vivo human tumor assay shows distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes. J. Invest. Dermatol. 139, 213–223 (2019). This study demonstrates in ex vivo tumour samples from patients that innate endocytosis is disrupted in squamous cell carcinoma.

doi: 10.1016/j.jid.2018.06.190

Lum, B. et al. Why does endocytosis inhibition lead to increased endosomal delivery of ADC/RLTs: pharmacological reversal. Cell Symposia: Hallmarks of Cancer (Fraunhofer ITEM, 2022).

Modi, S. et al. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer. N. Engl. J. Med. 387, 9–20 (2022).

doi: 10.1056/NEJMoa2203690

Zhang, J. et al. A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat. Commun. 12, 5460 (2021).

pmcid: 8443597 doi: 10.1038/s41467-021-25746-6

Yang, J. et al. Endocytosis pathway self-regulation for precise image-guided therapy through an enzyme-responsive modular peptide probe. Anal. Chem. 94, 7960–7969 (2022).

doi: 10.1021/acs.analchem.2c00776

Australian Clinical Trials. australianclinicaltrials.gov.au, https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12619001051134 (2019a).

Australian Clinical Trials. australianclinicaltrials.gov.au, https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12619001527156 (2019b).

Trochet, D. & Bitoun, M. A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target. J. Exp. Clin. Cancer Res. 40, 238 (2021).

pmcid: 8296698 doi: 10.1186/s13046-021-02045-y

Tremblay, C. S. et al. Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells. Nat. Commun. 11, 6211 (2020).

pubmed: 33277497 pmcid: 7719179 doi: 10.1038/s41467-020-20091-6

Feng, M. et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat. Rev. Cancer 19, 568–586 (2019).

pubmed: 31462760 pmcid: 7002027 doi: 10.1038/s41568-019-0183-z

Van Der Bliek, A. M. & Meyerowrtz, E. M. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature 351, 411–414 (1991).

pubmed: 1674590 doi: 10.1038/351411a0

Pereira, P. M. R. et al. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nat. Commun. 13, 2526 (2022). This study demonstrates the involvement of caveolin-1 in antibody drug efficacy.

pubmed: 35534471 pmcid: 9085816 doi: 10.1038/s41467-022-30142-9

Daniel, J. A. et al. Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic 16, 635–654 (2015).

pubmed: 25693808 doi: 10.1111/tra.12272

McCluskey, A. et al. Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic 14, 1272–1289 (2013).

pubmed: 24025110 pmcid: 4138991 doi: 10.1111/tra.12119

Bridge, J. A. et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am. J. Pathol. 159, 411–415 (2001).

pubmed: 11485898 pmcid: 1850566 doi: 10.1016/S0002-9440(10)61711-7

Reis, C. R. et al. Crosstalk between Akt/GSK3β signaling and dynamin-1 regulates clathrin-mediated endocytosis. EMBO J. 34, 2132–2146 (2015).

pubmed: 26139537 pmcid: 4557666 doi: 10.15252/embj.201591518

Eppinga, R. D. et al. Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. Oncogene 31, 1228–1241 (2012).

pubmed: 21841817 doi: 10.1038/onc.2011.329

Lee, Y. Y. et al. Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix. Cancer Biol. Ther. 10, 329–335 (2010).

pubmed: 20574164 doi: 10.4161/cbt.10.4.12275

Inokawa, Y. et al. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. OncoTargets Ther. 6, 1417–1424 (2013).

doi: 10.2147/OTT.S51913

Fa, J. Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells. Oncol. Lett. 22, 524 (2021).

pmcid: 8130055 doi: 10.3892/ol.2021.12785

Lu, Q. et al. Dynamin 3 inhibits the proliferation of non-small-cell lung cancer cells by suppressing c-MET-GBR2-STAT3 complex formation. Front. Cell Dev. Biol. 9, 641403 (2021).

pmcid: 8416685 doi: 10.3389/fcell.2021.641403

Jiao, J., Jiang, L. & Luo, Y. N6-methyladenosine-related RNA signature predicting the prognosis of ovarian cancer. Recent. Pat. Anticancer Drug Discov. 16, 407–416 (2021).

doi: 10.2174/1574892816666210615164645

Huang, P., Guo, Y.-D. & Zhang, H.-W. Identification of Hub genes in pediatric medulloblastoma by multiple-microarray analysis. J. Mol. Neurosci. 70, 522–531 (2020).

doi: 10.1007/s12031-019-01451-4

Saafan, H. et al. Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer – Proof of concept towards a systems pharmacology approach. Eur. J. Pharm. Sci. 94, 20–32 (2016).

doi: 10.1016/j.ejps.2016.04.025

Kaikkonen, E., Takala, A., Pursiheimo, J.-P., Wahlström, G. & Schleutker, J. The interactome of the prostate-specific protein Anoctamin 7. Cancer Biomark. 28, 91–100 (2020).

pmcid: 7306890 doi: 10.3233/CBM-190993

Rangel, R. et al. Identification of new tumor suppressor genes in triple-negative breast cancer. Cancer Res. 77, 4089–4101 (2017).

doi: 10.1158/0008-5472.CAN-17-0785

Cho, S. H. et al. The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma. J. Cell. Biochem. 120, 4140–4146 (2019).

doi: 10.1002/jcb.27699

Wu, C.-C., Li, H., Xiao, Y., Deng, W.-W. & Sun, Z.-J. Expression levels of SIX1, ME2, and AP2M1 in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral. Dis. 26, 1687–1695 (2020).

doi: 10.1111/odi.13506

Buser, D. P. et al. Quantitative proteomics reveals reduction of endocytic machinery components in gliomas. EBioMedicine 46, 32–41 (2019).

pmcid: 6711119 doi: 10.1016/j.ebiom.2019.07.039

Rogaia, D. et al. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner. Cancer Res. 57, 799–802 (1997).

Yamamoto, K. et al. Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23). Cancer Genet. 254-255, 92–97 (2021).

doi: 10.1016/j.cancergen.2021.02.006

Coon, B. G., Burgner, J., Camonis, J. H. & Aguilar, R. C. The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. J. Biol. Chem. 285, 33073–33081 (2010).

pmcid: 2963371 doi: 10.1074/jbc.M110.124123

Spradling, K. D., McDaniel, A. E., Lohi, J. & Pilcher, B. K. Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia. J. Biol. Chem. 276, 29257–29267 (2001).

doi: 10.1074/jbc.M101663200

Wang, Y., Dai, Z., Sadee, W. & Hancock, W. S. A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. Mol. Pharm. 3, 566–578 (2006).

doi: 10.1021/mp060002b

Tessneer, K. L. et al. Endocytic adaptor protein epsin is elevated in prostate cancer and required for cancer progression. ISRN Oncol. 2013, 420597 (2013).

pubmed: 23691361 pmcid: 3649151

Pawlowski, K. M. et al. Comparison of cellular and tissue transcriptional profiles in canine mammary tumor. J. Physiol. Pharmacol. 60, 85–94 (2009).

Caligiuri, M. A. et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood 110, 1022–1024 (2007).

pmcid: 1924768 doi: 10.1182/blood-2006-12-061176

Belizaire, R. et al. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. Blood 137, 2209–2220 (2021).

pmcid: 8063090 doi: 10.1182/blood.2020006528

Davidson, B. et al. Caveolin-1 expression in advanced-stage ovarian carcinoma — a clinicopathologic study. Gynecol. Oncol. 81, 166–171 (2001).

pubmed: 11330944 doi: 10.1006/gyno.2001.6156

Savage, K. et al. Caveolin 1 Is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin. Cancer Res. 13, 90–101 (2007).

pubmed: 17200343 doi: 10.1158/1078-0432.CCR-06-1371

Yan, J., Lu, Q., Cai, L., Li, X. W. & Dong, J. H. Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof. Zhonghua Yi Xue Za Zhi 88, 3272–3274 (2008).

pubmed: 19159553

Hung, K.-F. et al. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J. Oral. Pathol. Med. 32, 461–467 (2003).

pubmed: 12901727 doi: 10.1034/j.1600-0714.2003.00185.x

Cantiani, L. et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and Met signaling. Cancer Res. 67, 7675–7685 (2007).

pubmed: 17699771 doi: 10.1158/0008-5472.CAN-06-4697

Campbell, L. et al. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. J. Transl. Med. 11, 255 (2013).

pmcid: 4015803 doi: 10.1186/1479-5876-11-255

Chatterjee, M. et al. Caveolin-1 is associated with tumor progression and confers a multi-modality resistance phenotype in pancreatic cancer. Sci. Rep. 5, 10867 (2015).

pubmed: 26065715 pmcid: 4464260 doi: 10.1038/srep10867

Ando, T. et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol. Rep. 18, 601–609 (2007).

Iwaya, K., Norio, K. & Mukai, K. Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma. Mod. Pathol. 20, 339–343 (2007).

doi: 10.1038/modpathol.3800741

Iwaya, K. et al. Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci. 98, 992–999 (2007).

pubmed: 17459058 doi: 10.1111/j.1349-7006.2007.00488.x

Semba, S. et al. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin. Cancer Res. 12, 2449–2454 (2006).

doi: 10.1158/1078-0432.CCR-05-2566

Liu, Z. et al. Expression of the Arp2/3 complex in human gliomas and its role in the migration and invasion of glioma cells. Oncol. Rep. 30, 2127–2136 (2013).

doi: 10.3892/or.2013.2669

Gligorijevic, B. et al. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J. Cell Sci. 125, 724–734 (2012).

pubmed: 22389406 pmcid: 3367832 doi: 10.1242/jcs.092726

Ishihara, D. et al. Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis. Cell Rep. 4, 429–436 (2013).

pubmed: 23911287 pmcid: 3777703 doi: 10.1016/j.celrep.2013.07.007

Fernando, H. S., Sanders, A. J., Kynaston, H. G. & Jiang, W. G. WAVE1 is associated with invasiveness and growth of prostate cancer cells. J. Urol. 180, 1515–1521 (2008).

pubmed: 18710763 doi: 10.1016/j.juro.2008.06.004

Fernando, H. S., Sanders, A. J., Kynaston, H. G. & Jiang, W. G. WAVE3 is associated with invasiveness in prostate cancer cells. Urol. Oncol.: Semin. Orig. Investig. 28, 320–327 (2010).

doi: 10.1016/j.urolonc.2008.12.022

Taylor, M. A. et al. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res. Treat. 142, 341–353 (2013).

pubmed: 24197660 pmcid: 3888319 doi: 10.1007/s10549-013-2753-1

Sossey-Alaoui, K. et al. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am. J. Pathol. 170, 2112–2121 (2007).

pubmed: 17525277 pmcid: 1899429 doi: 10.2353/ajpath.2007.060975

Kang, R. et al. WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells. Leukemia 24, 177–186 (2010).

pubmed: 19890377 doi: 10.1038/leu.2009.224

Kurisu, S., Suetsugu, S., Yamazaki, D., Yamaguchi, H. & Takenawa, T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24, 1309–1319 (2005).

pubmed: 15608687 doi: 10.1038/sj.onc.1208177

Sossey-Alaoui, K., Su, G., Malaj, E., Roe, B. & Cowell, J. K. WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 21, 5967–5974 (2002).

pubmed: 12185600 doi: 10.1038/sj.onc.1205734

Clark, E. S., Whigham, A. S., Yarbrough, W. G. & Weaver, A. M. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67, 4227–4235 (2007).

pubmed: 17483334 doi: 10.1158/0008-5472.CAN-06-3928

Clark, E. S. & Weaver, A. M. A new role for cortactin in invadopodia: regulation of protease secretion. Eur. J. Cell Biol. 87, 581–590 (2008).

pubmed: 18342393 pmcid: 2566933 doi: 10.1016/j.ejcb.2008.01.008

Luo, M.-L. et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res. 66, 11690–11699 (2006).

pubmed: 17178864 doi: 10.1158/0008-5472.CAN-06-1484

Hui, R. et al. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 17, 1053–1059 (1998).

pubmed: 9747885 doi: 10.1038/sj.onc.1202023

Yuan, B.-Z., Zhou, X., Zimonjic, D. B., Durkin, M. E. & Popescu, N. C. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J. Mol. Diagn. 5, 48–53 (2003).

pubmed: 12552080 pmcid: 1907373 doi: 10.1016/S1525-1578(10)60451-5

Zaharieva, B. M. et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J. Pathol. 201, 603–608 (2003).

pubmed: 14648664 doi: 10.1002/path.1481

Wang, L. et al. Expression of cortactin in human gliomas and its effect on migration and invasion of glioma cells. Oncol. Rep. 34, 1815–1824 (2015).

pubmed: 26238396 doi: 10.3892/or.2015.4156

Timpson, P., Lynch, D. K., Schramek, D., Walker, F. & Daly, R. J. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res. 65, 3273–3280 (2005).

pubmed: 15833860 doi: 10.1158/0008-5472.CAN-04-2118

Kalpana, G., Figy, C., Yeung, M. & Yeung, K. C. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling. Sci. Rep. 9, 16351 (2019).

pubmed: 31705019 pmcid: 6841971 doi: 10.1038/s41598-019-52746-w

Kamai, T. et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin. Cancer Res. 10, 4799–4805 (2004).

pubmed: 15269155 doi: 10.1158/1078-0432.CCR-0436-03

Fritz, G., Brachetti, C., Bahlmann, F., Schmidt, M. & Kaina, B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87, 635–644 (2002).

pubmed: 12237774 pmcid: 2364248 doi: 10.1038/sj.bjc.6600510

Horiuchi, A. et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 83, 861–870 (2003).

pubmed: 12808121 doi: 10.1097/01.LAB.0000073128.16098.31

Pan, Y. et al. Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315, 686–691 (2004).

pubmed: 14975755 doi: 10.1016/j.bbrc.2004.01.108

Kamai, T. et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9, 2632–2641 (2003).

pubmed: 12855641

Gómez del Pulgar, T., Benitah, S. A., Valerón, P. F., Espina, C. & Lacal, J. C. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 27, 602–613 (2005).

pubmed: 15892119 doi: 10.1002/bies.20238

So, C. W. et al. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc. Natl Acad. Sci. USA 94, 2563–2568 (1997).

pubmed: 9122235 pmcid: 20128 doi: 10.1073/pnas.94.6.2563

Baldassarre, T. et al. Endophilin A2 promotes TNBC cell invasion and tumor metastasis. Mol. Cancer Res. 13, 1044–1055 (2015).

pubmed: 25784716 doi: 10.1158/1541-7786.MCR-14-0573

Baldassarre, T., Truesdell, P. & Craig, A. W. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Breast Cancer Res 19, 110 (2017).

pubmed: 28974266 pmcid: 5627411 doi: 10.1186/s13058-017-0900-z

Fan, H., Zhao, X., Sun, S., Luo, M. & Guan, J. L. Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo. J. Biol. Chem. 288, 3322–3333 (2013).

pubmed: 23255596 doi: 10.1074/jbc.M112.420497

Wu, X., Gan, B., Yoo, Y. & Guan, J.-L. FAK-mediated Src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev. Cell 9, 185–196 (2005).

pubmed: 16054026 doi: 10.1016/j.devcel.2005.06.006

Yang, X., Ren, H., Yao, L., Chen, X. & He, A. Role of EHD2 in migration and invasion of human breast cancer cells. Tumor Biol. 36, 3717–3726 (2015).

doi: 10.1007/s13277-014-3011-9

Liu, J. et al. Decreased expression of EHD2 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Dig. Dis. Sci. 61, 2554–2567 (2016).

pubmed: 27221498 doi: 10.1007/s10620-016-4202-6

Guan, C., Lu, C., Xiao, M. & Chen, W. EHD2 overexpression suppresses the proliferation, migration, and invasion in human colon cancer. Cancer Invest. 39, 297–309 (2021).

pubmed: 33356637

Li, M. et al. Effects of EHD2 interference on migration of esophageal squamous cell carcinoma. Med. Oncol. 30, 396 (2013).

pubmed: 23354948 pmcid: 3586404 doi: 10.1007/s12032-012-0396-4

Kim, Y. et al. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma. PLoS ONE 12, e0174737 (2017).

pubmed: 28358874 pmcid: 5373597 doi: 10.1371/journal.pone.0174737

Liu, C. et al. Effect of EH domain containing protein 2 on the biological behavior of clear cell renal cell carcinoma. Hum. Exp. Toxicol. 38, 927–937 (2019).

pubmed: 30995867 doi: 10.1177/0960327119842241

Huh, Y. H. et al. Swiprosin-1 stimulates cancer invasion and metastasis by increasing the Rho family of GTPase signaling. Oncotarget 6, 13060–13071 (2015).

pubmed: 26079945 pmcid: 4536999 doi: 10.18632/oncotarget.3637

Fan, C. C. et al. EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. Redox Biol. 34, 101571 (2020).

pubmed: 32446175 pmcid: 7243194 doi: 10.1016/j.redox.2020.101571

Boulay, P. L. et al. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein. Oncogene 30, 3846–3861 (2011).

pubmed: 21478909 doi: 10.1038/onc.2011.100

Schlienger, S., Ramirez, R. A. & Claing, A. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions. Cell. Signal. 27, 403–415 (2015).

pubmed: 25530216 doi: 10.1016/j.cellsig.2014.11.032

Schlienger, S., Campbell, S. & Claing, A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol. Biol. Cell. 25, 17–29 (2014).

pubmed: 24196838 pmcid: 3873888 doi: 10.1091/mbc.e13-06-0335

Rainero, E. et al. Ligand-occupied integrin internalization links nutrient signaling to invasive migration. Cell Rep. 10, 398–413 (2015).

pubmed: 25600874 doi: 10.1016/j.celrep.2014.12.037

Palacios, F., Price, L., Schweitzer, J., Collard, J. G. & D’Souza-Schorey, C. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 20, 4973–4986 (2001).

pubmed: 11532961 pmcid: 125602 doi: 10.1093/emboj/20.17.4973

Morishige, M. et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat. Cell Biol. 10, 85–92 (2008).

pubmed: 18084281 doi: 10.1038/ncb1672

Schlienger, S., Campbell, S., Pasquin, S., Gaboury, L. & Claing, A. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Oncotarget 7, 15811–15827 (2016).

pubmed: 26908458 pmcid: 4941279 doi: 10.18632/oncotarget.7515

Zhao, H. et al. Coexpression of IQ-domain GTPase-activating protein 1 (IQGAP1) and dishevelled (Dvl) is correlated with poor prognosis in non-small cell lung cancer. PLoS ONE 9, e113713 (2014).

pubmed: 25436461 pmcid: 4249885 doi: 10.1371/journal.pone.0113713

Yang, Z. et al. Overexpression of PAK1 correlates with aberrant expression of EMT markers and poor prognosis in non-small cell lung cancer. J. Cancer 8, 1484–1491 (2017).

pubmed: 28638464 pmcid: 5479255 doi: 10.7150/jca.18553

Lin, C.-H. et al. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Biochim. Biophys. Acta - Mol. Cell Res. 1833, 2823–2833 (2013).

doi: 10.1016/j.bbamcr.2013.07.016

Wang, G. et al. PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion. Cell Death Dis. 6, e1682 (2015).

pubmed: 25766321 pmcid: 4385928 doi: 10.1038/cddis.2015.50

Wang, G. et al. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis. Oncotarget 6, 9877–9886 (2015).

pmcid: 4496403 doi: 10.18632/oncotarget.3185

Mishra, P., Senthivinayagam, S., Rangasamy, V., Sondarva, G. & Rana, B. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation. Mol. Endocrinol. 24, 598–607 (2010).

pmcid: 5419095 doi: 10.1210/me.2009-0387

Pichot, C. S. et al. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Res. 70, 8347–8356 (2010).

pmcid: 2970640 doi: 10.1158/0008-5472.CAN-09-4149

Sanchez, A. M. et al. Estrogen receptor-α promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol. Endocrinol. 24, 2114–2125 (2010).

pmcid: 5417375 doi: 10.1210/me.2010-0252

Martin, T. A., Pereira, G., Watkins, G., Mansel, R. E. & Jiang, W. G. N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clin. Exp. Metastasis 25, 97–108 (2008).

doi: 10.1007/s10585-007-9120-8

Arias-Romero, L. E., Villamar-Cruz, O., Huang, M., Hoeflich, K. P. & Chernoff, J. Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells. Cancer Res. 73, 3671–3682 (2013).

pmcid: 3687032 doi: 10.1158/0008-5472.CAN-12-4453

Rattanasinchai, C., Llewellyn, B. J., Conrad, S. E. & Gallo, K. A. MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis 6, e345 (2017).

pmcid: 5519193 doi: 10.1038/oncsis.2017.44

Blessing, N. A., Brockman, A. L. & Chadee, D. N. The E3 ligase CHIP mediates ubiquitination and degradation of mixed-lineage kinase 3. Mol. Cell. Biol. 34, 3132–3143 (2014).

pmcid: 4135596 doi: 10.1128/MCB.00296-14

Wang, W.-S. et al. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Dis. Esophagus 23, 512–521 (2010).

doi: 10.1111/j.1442-2050.2009.01035.x

Zhang, Y. et al. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 28, 565–575 (2013).

doi: 10.1111/j.1440-1746.2012.07271.x

Aguilar, B. J., Zhou, H. & Lu, Q. Cdc42 signaling pathway inhibition as a therapeutic target in Ras- related cancers. Curr. Med. Chem. 24, 3485–3507 (2017).

doi: 10.2174/0929867324666170602082956

Frittoli, E. et al. A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination. J. Cell Biol. 206, 307–328 (2014).

pmcid: 4107781 doi: 10.1083/jcb.201403127

Karthikeyan, S., Casey, P. J. & Wang, M. RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation. Breast Cancer Res. 24, 72 (2022).

pmcid: 9615386 doi: 10.1186/s13058-022-01564-6

Tubbesing, K. et al. Complex Rab4-mediated regulation of endosomal size and EGFR activation. Mol. Cancer Res. 18, 757–773 (2020).

pmcid: 7526990 doi: 10.1158/1541-7786.MCR-19-0052

Yang, P.-S. et al. Rab5A is associated with axillary lymph node metastasis in breast cancer patients. Cancer Sci. 102, 2172–2178 (2011).

doi: 10.1111/j.1349-7006.2011.02089.x

Díaz, J. et al. Rab5 is required in metastatic cancer cells for caveolin-1-enhanced Rac1 activation, migration and invasion. J. Cell Sci. 127, 2401–2406 (2014).

pmcid: 4074264

Silva, P. et al. Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis. Oncotarget 7, 29548–29562 (2016).

pmcid: 5045416 doi: 10.18632/oncotarget.8794

Margiotta, A., Progida, C., Bakke, O. & Bucci, C. Rab7a regulates cell migration through Rac1 and vimentin. Biochim. Biophys. Acta Mol. Cell Res. 1864, 367–381 (2017).

doi: 10.1016/j.bbamcr.2016.11.020

Wang, T. et al. A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal. J. Cell. Physiol. 227, 2788–2797 (2012).

doi: 10.1002/jcp.23023

Williams, K. C. & Coppolino, M. G. Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration. J. Biol. Chem. 286, 43405–43416 (2011).

pmcid: 3234865 doi: 10.1074/jbc.M111.297069

Steffan, J. J. & Cardelli, J. A. Thiazolidinediones induce Rab7–RILP–MAPK-dependent juxtanuclear lysosome aggregation and reduce tumor cell invasion. Traffic 11, 274–286 (2010).

doi: 10.1111/j.1600-0854.2009.01012.x

Steffan, J. J. et al. Supporting a role for the GTPase Rab7 in prostate cancer progression. PLoS ONE 9, e87882 (2014).

pmcid: 3914878 doi: 10.1371/journal.pone.0087882

Wang, W. et al. Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A. Proc. Natl Acad. Sci. USA 114, 8366–8371 (2017).

pmcid: 5547599 doi: 10.1073/pnas.1701289114

Alonso-Curbelo, D. et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell 26, 61–76 (2014).

doi: 10.1016/j.ccr.2014.04.030

Howe, E. N. et al. Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth. Nat. Commun. 11, 3017 (2020).

pmcid: 7295786 doi: 10.1038/s41467-020-16832-2

Palmieri, D., Bouadis, A., Ronchetti, R., Merino, M. J. & Steeg, P. S. Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells. Breast Cancer Res. Treat. 100, 127–137 (2006).

doi: 10.1007/s10549-006-9244-6

Yu, L., Li, X., Li, H., Chen, H. & Liu, H. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer. Tumor Biol. 37, 13821–13829 (2016).

doi: 10.1007/s13277-016-5172-1

Dong, Q. et al. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer. Oncotarget 8, 27800–27811 (2017).

pmcid: 5438609 doi: 10.18632/oncotarget.15359

Zhang, Z.-Y. et al. Rab11a regulates MMP2 expression by activating the PI3K/AKT pathway in human hepatocellular carcinoma cells. Pathol. Res. Pract. 216, 153046 (2020).

doi: 10.1016/j.prp.2020.153046

D’Agostino, L. et al. Recycling endosomes in mature epithelia restrain tumorigenic signaling. Cancer Res. 79, 4099–4112 (2019).

pmcid: 6726494 doi: 10.1158/0008-5472.CAN-18-4075

Yoon, S.-O., Shin, S. & Mercurio, A. M. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the α6β4 integrin. Cancer Res. 65, 2761–2769 (2005).

pubmed: 15805276 doi: 10.1158/0008-5472.CAN-04-4122

Zhang, J. et al. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Carcinogenesis 34, 2401–2408 (2013).

pubmed: 23722651 doi: 10.1093/carcin/bgt187

Cao, C. et al. Expression of Rab25 correlates with the invasion and metastasis of gastric cancer. Chin. J. Cancer Res. 25, 192–199 (2013).

pubmed: 23592900 pmcid: 3626988

Geng, D., Zhao, W., Feng, Y. & Liu, J. Overexpression of Rab25 promotes hepatocellular carcinoma cell proliferation and invasion. Tumor Biol. 37, 7713–7718 (2016).

doi: 10.1007/s13277-015-4606-5

Ma, Y. F. et al. Expression of Ras-related protein 25 predicts chemotherapy resistance and prognosis in advanced non-small cell lung cancer. Gen. Mol. Res. 14, 13998–14008 (2015).

doi: 10.4238/2015.October.29.19

Cheng, K. W. et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10, 1251–1256 (2004).

pubmed: 15502842 doi: 10.1038/nm1125

Jeong, B. Y. et al. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin. Exp. Mol. Med. 50, e435 (2018).

pubmed: 29371698 pmcid: 5799805 doi: 10.1038/emm.2017.248

Kessler, D. et al. The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration. Cell. Physiol. Biochem. 29, 647–656 (2012).

pubmed: 22613965 doi: 10.1159/000295249

Hu, C., Chen, B., Zhou, Y. & Shan, Y. High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy. Cancer Cell Int. 17, 45 (2017).

pubmed: 28400705 pmcid: 5387234 doi: 10.1186/s12935-017-0411-0

Ding, B. et al. Knockdown of Ras-related protein 25 (Rab25) inhibits the in vitro cytotoxicity and in vivo antitumor activity of human glioblastoma multiforme cells. Oncol. Res. Feat. Preclin. Clin. Cancer Ther. 25, 331–340 (2017).

Nam, K. T. et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J. Clin. Investig. 120, 840–849 (2010).

pmcid: 2827957 doi: 10.1172/JCI40728

Tong, M. et al. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res. 72, 6024–6035 (2012).

doi: 10.1158/0008-5472.CAN-12-1269

Cheng, J.-M., Ding, M., Aribi, A., Shah, P. & Rao, K. Loss of RAB25 expression in breast cancer. Int. J. Cancer 118, 2957–2964 (2006).

doi: 10.1002/ijc.21739

Amornphimoltham, P. et al. Rab25 regulates invasion and metastasis in head and neck cancer. Clin. Cancer Res. 19, 1375–1388 (2013).

pmcid: 3602237 doi: 10.1158/1078-0432.CCR-12-2858

Hansen, S. H., Sandvig, K. & van Deurs, B. Molecules internalized by clathrin-independent endocytosis are delivered to endosomes containing transferrin receptors. J. Cell Biol. 123, 89–97 (1993).

doi: 10.1083/jcb.123.1.89

Carpentier, J. L. et al. Potassium depletion and hypertonic medium reduce “non-coated” and clathrin-coated pit formation, as well as endocytosis through these two gates. J. Cell. Physiol. 138, 519–526 (1989).

doi: 10.1002/jcp.1041380311

Larkin, J. M., Brown, M. S., Goldstein, J. L. & Anderson, R. G. Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts. Cell 33, 273–285 (1983).

doi: 10.1016/0092-8674(83)90356-2

Sasso, L., Purdie, L., Grabowska, A., Jones, A. T. & Alexander, C. Time and cell-dependent effects of endocytosis inhibitors on the internalization of biomolecule markers and nanomaterials. J. Interdiscip. Nanomed. 3, 67–81 (2018).

doi: 10.1002/jin2.39

Boucrot, E. et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature 517, 460–465 (2015).

doi: 10.1038/nature14067

Wang, L. H., Rothberg, K. G. & Anderson, R. G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123, 1107–1117 (1993).

doi: 10.1083/jcb.123.5.1107

Chen, C. L. et al. Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J. Cell Sci. 122, 1863–1871 (2009).

pubmed: 19461075 pmcid: 2684837 doi: 10.1242/jcs.038729

von Kleist, L. et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146, 471–484 (2011).

doi: 10.1016/j.cell.2011.06.025

Dutta, D., Williamson, C. D., Cole, N. B. & Donaldson, J. G. Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS ONE 7, e45799 (2012).

pmcid: 3448704 doi: 10.1371/journal.pone.0045799

Willox, A. K., Sahraoui, Y. M. & Royle, S. J. Non-specificity of Pitstop 2 in clathrin-mediated endocytosis. Biol. Open 3, 326–331 (2014).

pmcid: 4021354 doi: 10.1242/bio.20147955

Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).

doi: 10.1016/j.devcel.2006.04.002

Park, R. J. et al. Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. J. Cell Sci. 126, 5305–5312 (2013).

pmcid: 3828596

Kilsdonk, E. P. et al. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270, 17250–172566 (1995).

doi: 10.1074/jbc.270.29.17250

Hao, M., Mukherjee, S., Sun, Y. & Maxfield, F. R. Effects of cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes. J. Biol. Chem. 279, 14171–14178 (2004).

pubmed: 14734557 doi: 10.1074/jbc.M309793200

McKenney, J. M. Pharmacologic characteristics of statins. Clin. Cardiol. 26, 32–38 (2003).

doi: 10.1002/clc.4960261507

Chaudhary, N. et al. Endocytic crosstalk: cavins, caveolins, and caveolae regulate clathrin-independent endocytosis. PLoS Biol. 12, e1001832 (2014).

pmcid: 3979662 doi: 10.1371/journal.pbio.1001832

Rentero, C. et al. Functional implications of plasma membrane condensation for T cell activation. PLoS ONE 3, e2262 (2008).

pubmed: 18509459 pmcid: 2384009 doi: 10.1371/journal.pone.0002262

Thottacherry, J. J. et al. Mechanochemical feedback control of dynamin independent endocytosis modulates membrane tension in adherent cells. Nat. Commun. 9, 4217 (2018).

pubmed: 30310066 pmcid: 6181995 doi: 10.1038/s41467-018-06738-5

Akiyama, T. et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592–5595 (1987).

pubmed: 3106339 doi: 10.1016/S0021-9258(18)45614-1

Parton, R. G., Joggerst, B. & Simons, K. Regulated internalization of caveolae. J. Cell Biol. 127, 1199–1215 (1994).

pubmed: 7962085 doi: 10.1083/jcb.127.5.1199

Brenner, S. L. & Korn, E. D. Substoichiometric concentrations of cytochalasin D inhibit actin polymerization. Additional evidence for an F-actin treadmill. J. Biol. Chem. 254, 9982–9985 (1979).

pubmed: 489616 doi: 10.1016/S0021-9258(19)86660-7

Fujimoto, L. M., Roth, R., Heuser, J. E. & Schmid, S. L. Actin assembly plays a variable, but not obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic 1, 161–171 (2000).

pubmed: 11208096 doi: 10.1034/j.1600-0854.2000.010208.x

Gladhaug, I. P. & Christoffersen, T. Amiloride inhibits constitutive internalization and increases the surface number of epidermal growth factor receptors in intact rat hepatocytes. J. Cell. Physiol. 143, 188–195 (1990).

doi: 10.1002/jcp.1041430126

Kleyman, T. R. & Cragoe, E. J. Jr. Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. 105, 1–21 (1988).

pubmed: 2852254 doi: 10.1007/BF01871102

Henriksen, L., Grandal, M. V., Knudsen, S. L., van Deurs, B. & Grøvdal, L. M. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands. PLoS ONE 8, e58148 (2013).

pmcid: 3589378 doi: 10.1371/journal.pone.0058148

Le Roy, C. & Wrana, J. L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6, 112–126 (2005).

doi: 10.1038/nrm1571

Polo, S. Signaling-mediated control of ubiquitin ligases in endocytosis. BMC Biol. 10, 25 (2012).

pmcid: 3305638 doi: 10.1186/1741-7007-10-25

Ford, M. G. J. et al. Curvature of clathrin-coated pits driven by epsin. Nature 419, 361–366 (2002).

doi: 10.1038/nature01020

Pearse, B. M. F. Coated vesicles from pig brain: purification and biochemical characterization. J. Mol. Biol. 97, 93–98 (1975).

doi: 10.1016/S0022-2836(75)80024-6

Schmid, S. L. & Frolov, V. A. Dynamin: functional design of a membrane fission catalyst. Annu. Rev. Cell. Dev. Biol. 27, 79–105 (2011).

pubmed: 21599493 doi: 10.1146/annurev-cellbio-100109-104016

Yarar, D., Waterman-Storer, C. M. & Schmid, S. L. A dynamic actin cytoskeleton functions at multiple stages of clathrin-mediated endocytosis. Mol. Biol. Cell. 16, 964–975 (2005).

pubmed: 15601897 pmcid: 545926 doi: 10.1091/mbc.e04-09-0774

Kaksonen, M., Toret, C. P. & Drubin, D. G. A modular design for the clathrin- and actin-mediated endocytosis machinery. Cell 123, 305–320 (2005).

pubmed: 16239147 doi: 10.1016/j.cell.2005.09.024

Parton, R. G. & Simons, K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185–194 (2007).

pubmed: 17318224 doi: 10.1038/nrm2122

Pelkmans, L., Bürli, T., Zerial, M. & Helenius, A. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118, 767–780 (2004).

pubmed: 15369675 doi: 10.1016/j.cell.2004.09.003

Hill, M. M. et al. PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113–124 (2008).

pubmed: 18191225 pmcid: 2265257 doi: 10.1016/j.cell.2007.11.042

Kovtun, O., Tillu, V. A., Ariotti, N., Parton, R. G. & Collins, B. M. Cavin family proteins and the assembly of caveolae. J. Cell Sci. 128, 1269–1278 (2015).

pubmed: 25829513 pmcid: 4379724 doi: 10.1242/jcs.167866

Vinten, J., Johnsen, A. H., Roepstorff, P., Harpøth, J. & Tranum-Jensen, J. Identification of a major protein on the cytosolic face of caveolae. Biochim. Biophys. Acta Biomembr. 1717, 34–40 (2005).

doi: 10.1016/j.bbamem.2005.09.013

Torrino, S. et al. EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription. J. Cell Biol. 217, 4092–4105 (2018).

pubmed: 30348749 pmcid: 6279385 doi: 10.1083/jcb.201801122

Casamento, A. & Boucrot, E. Molecular mechanism of fast endophilin-mediated endocytosis. Biochem. J. 477, 2327–2345 (2020).

pubmed: 32589750 doi: 10.1042/BCJ20190342

Hinze, C. & Boucrot, E. Local actin polymerization during endocytic carrier formation. Biochem. Soc. Trans. 46, 565–576 (2018).

pubmed: 29678956 doi: 10.1042/BST20170355

Massol, P., Montcourrier, P., Guillemot, J.-C. & Chavrier, P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 17, 6219–6229 (1998).

pubmed: 9799231 pmcid: 1170948 doi: 10.1093/emboj/17.21.6219

Schlam, D. et al. Phosphoinositide 3-kinase enables phagocytosis of large particles by terminating actin assembly through Rac/Cdc42 GTPase-activating proteins. Nat. Commun. 6, 8623 (2015).

pubmed: 26465210 doi: 10.1038/ncomms9623

Park, H. & Cox, D. Cdc42 regulates Fcγ receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich Syndrome protein (WASP) and neural-WASP. Mol. Biol. Cell. 20, 4500–4508 (2009).

pubmed: 19741094 pmcid: 2770938 doi: 10.1091/mbc.e09-03-0230

Lee, D. J., Cox, D., Li, J. & Greenberg, S. Rac1 and Cdc42 are required for phagocytosis, but not NF-κB-dependent gene expression, in macrophages challenged with Pseudomonas aeruginosa. J. Biol. Chem. 275, 141–146 (2000).

pubmed: 10617597 doi: 10.1074/jbc.275.1.141

Rotty, J. D. et al. Arp2/3 complex is required for macrophage integrin functions but is dispensable for FcR phagocytosis and in vivo motility. Dev. Cell 42, 498–513 (2017).

pubmed: 28867487 pmcid: 5601320 doi: 10.1016/j.devcel.2017.08.003

May, R. C., Caron, E., Hall, A. & Machesky, L. M. Involvement of the Arp2/3 complex in phagocytosis mediated by FcγR or CR3. Nat. Cell Biol. 2, 246–248 (2000).

pubmed: 10783245 doi: 10.1038/35008673

Velle, K. B. & Fritz-Laylin, L. K. Conserved actin machinery drives microtubule-independent motility and phagocytosis in Naegleria. J. Cell Biol. 219, e202007158 (2020).

pubmed: 32960946 pmcid: 7594500 doi: 10.1083/jcb.202007158

Jaumouillé, V., Cartagena-Rivera, A. X. & Waterman, C. M. Coupling of β2 integrins to actin by a mechanosensitive molecular clutch drives complement receptor-mediated phagocytosis. Nat. Cell Biol. 21, 1357–1369 (2019).

pubmed: 31659275 pmcid: 6858589 doi: 10.1038/s41556-019-0414-2

Castellano, F., Chavrier, P. & Caron, E. Actin dynamics during phagocytosis. Semin. Immunol. 13, 347–355 (2001).

pubmed: 11708890 doi: 10.1006/smim.2001.0331

Haga, Y., Miwa, N., Jahangeer, S., Okada, T. & Nakamura, S.-i CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis. EMBO J. 28, 1197–1207 (2009).

pubmed: 19322195 pmcid: 2664659 doi: 10.1038/emboj.2009.78

Liberali, P. et al. The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J. 27, 970–981 (2008).

pubmed: 18354494 pmcid: 2323256 doi: 10.1038/emboj.2008.59

Condon, N. D. et al. Macropinosome formation by tent pole ruffling in macrophages. J. Cell Biol. 217, 3873–3885 (2018).

pubmed: 30150290 pmcid: 6219714 doi: 10.1083/jcb.201804137

Veltman, D. M. et al. A plasma membrane template for macropinocytic cups. eLife 5, e20085 (2016).

pubmed: 27960076 pmcid: 5154761 doi: 10.7554/eLife.20085

Williamson, C. D. & Donaldson, J. G. Arf6, JIP3, and dynein shape and mediate macropinocytosis. Mol. Biol. Cell. 30, 1477–1489 (2019).

pubmed: 30969891 pmcid: 6724687 doi: 10.1091/mbc.E19-01-0022

Junemann, A. et al. A Diaphanous-related formin links Ras signaling directly to actin assembly in macropinocytosis and phagocytosis. Proc. Natl Acad. Sci. USA 113, 7464–7473 (2016).

doi: 10.1073/pnas.1611024113

Kumari, S. & Mayor, S. ARF1 is directly involved in dynamin-independent endocytosis. Nat. Cell Biol. 10, 30–41 (2008).

pubmed: 18084285 doi: 10.1038/ncb1666

Sabharanjak, S., Sharma, P., Parton, R. G. & Mayor, S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2, 411–423 (2002).

doi: 10.1016/S1534-5807(02)00145-4

Chadda, R. et al. Cholesterol-sensitive Cdc42 activation regulates actin polymerization for endocytosis via the GEEC pathway. Traffic 8, 702–717 (2007).

doi: 10.1111/j.1600-0854.2007.00565.x

Schnatwinkel, C. et al. The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms. PLoS Biol. 2, E261 (2004).

pmcid: 514490 doi: 10.1371/journal.pbio.0020261

Donaldson, J. G. Macropinosome formation, maturation and membrane recycling: lessons from clathrin-independent endosomal membrane systems. Philos. Trans. R. Soc. B: Biol. Sci. 374, 20180148 (2019).

doi: 10.1098/rstb.2018.0148

Burr, M. L. et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101–105 (2017).

pmcid: 5706633 doi: 10.1038/nature23643

Mezzadra, R. et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature 549, 106–110 (2017).

pmcid: 6333292 doi: 10.1038/nature23669

Clynes, R. A., Towers, T. L., Presta, L. G. & Ravetch, J. V. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6, 443–446 (2000).

doi: 10.1038/74704

Cartron, G. et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 99, 754–758 (2002).

doi: 10.1182/blood.V99.3.754

Beano, A. et al. Correlation between NK function and response to trastuzumab in metastatic breast cancer patients. J. Transl. Med. 6, 25 (2008).

pmcid: 2415031 doi: 10.1186/1479-5876-6-25

Blomberg, O. S. et al. IL-5-producing CD4

doi: 10.1016/j.ccell.2022.11.014

Shi, Y. et al. Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages. J. Immun. 194, 4379–4386 (2015).

doi: 10.4049/jimmunol.1402891

Endocytosis in cancer and cancer therapy.

Journal

Informations de publication

Résumé

Identifiants

Substances chimiques

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Blerida Banushi (B)

Shannon R Joseph (SR)

Benedict Lum (B)

Jason J Lee (JJ)

Fiona Simpson (F)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH